NMDP Named ‘Best Place to Work’ Fourth Year in a Row
August 23, 2024 12:58 ET
|
NMDP
Global cell therapy nonprofit honored in top 3 of the 'extra large' companies, recognizing its exceptional employees, workplace culture and life-saving mission MINNEAPOLIS, Aug. 23, 2024 (GLOBE...
NMDP℠ Raises More Than $235,000 at Annual LA Gala Fundraiser
August 13, 2024 10:00 ET
|
NMDP
NMDP recently hosted its annual gala in Los Angeles to raise critical funds that support patient financial assistance and innovation in cell therapy.
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Saving Cell Therapy
May 08, 2024 14:46 ET
|
NMDP
The annual NMDP Gala in New York raises critical funds, enabling more patients to receive life-saving cell therapy.
NMDP’s Amy Ronneberg Recognized as Most Admired CEO by Minneapolis/St. Paul Business Journal
May 06, 2024 14:17 ET
|
NMDP
The Minneapolis / St. Paul Business Journal named NMDP CEO Amy Ronneberg to its 2024 list of Most Admired CEOs.
NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting
April 24, 2024 10:43 ET
|
NMDP
NMDP to present new data on hematopoietic cell transplantation treatment effects in patients with hematological malignancies at ASCO.
NMDP Cycle Kicks Off Nationwide Cycling Events Giving Hope to Patients in Need of a Blood Stem Cell Transplant
March 29, 2024 11:19 ET
|
NMDP
MINNEAPOLIS, March 29, 2024 (GLOBE NEWSWIRE) -- NMDPSM Cycle (formerly Be The Match® Tour de TC) kicks off March 30 on a six-ride tour throughout the country to raise funds to help remove barriers...
NMDP Receives Record-Breaking $5 Million Philanthropic Gift
March 19, 2024 11:11 ET
|
NMDP
NMDP recently received a $5 million gift from the Moore family to support the organization’s mission of advancing cell therapy research.
NMDP Awards 25th Annual ‘Amy Scholars’ Grant, Furthering Post-Transplant Research
March 06, 2024 10:29 ET
|
NMDP
NMDP announced two recipients of its Amy Strelzer Manasevit Research Program grant and the first Barbara Buchbinder Nurse Research Grant recipient.
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
February 20, 2024 08:00 ET
|
NMDP
Groundbreaking Trial Seeks to Enhance Blood Cancer Treatment Efficacy and Safety.
NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development
January 30, 2024 09:00 ET
|
NMDP
NMDP BioTherapies℠, formerly Be The Match BioTherapies, announced that Tom Hochuli will serve as president.